Decent announcement today - nothing flash but enough to remove...

Decent announcement today - nothing flash but enough to remove some more supply from the large seller (probably Regal given the size, as others have noted on here).

On a positive note, we saw 24 million go through today following the ~75 million on Friday, suggesting the the large seller may either be out or probably out tomorrow. There's a good chance we'll be updated on this substantial position change within days. The best news is that they buy side is stacked at 1.1 cents and building at 1 cent. Furthermore someone's clearly absorbing the ~100 mill sale because the share price is holding up nicely. There's a chance that Regal notified the company of its attention ahead of time and a buyer was lined up before the selling.

So we got an announcement that the trial has ended with a decent response from employees at ~65%. The best news, of course, is that MEB will keep working with Compass. There's two additional pilot programs starting now (signed in July) and a fourth pilot to start in January (signed in August). This suggests that things are starting to heat up for the company, especially with the FDA submission planned for November. That means the wheels are starting to turn and we could start to see the share price wake up over the coming months, especially as we move into 2020 with the potential of Compass signing a binding deal for Ilumen, which it could role out company wide. We then have the potential to start trials with other major multinational companies interested in the mental health of its employees (many companies).

Of course the big share price kicker will likely come as we move into 2020, with the potential of getting an FDA approval nearing and commercialising the more expensive product alongside Ilumen gaining traction.

The bottom line: everything seems on track for a higher share price. Yes we're seeing some large seller trying to get out. But, fundamentally speaking, everything looks good and the story is gaining momentum. Technically speaking, the share price is holding up with tremendous support. So we're liking what we're seeing here and could be in for a big few months, with the FDA submission possibly kick starting the show next month. Might actually load up with some more shares, TBH, while they are going cheap.
To your first million,
-Trading For Millions